Skip to content

Addiction: all studies

Page 677 of 857: studies 6,761 to 6,770 of 8,563, newest first. Back to the addiction overview

Research

A phenomenology of meditation-induced light experiences: traditional buddhist and neurobiological perspectives

Frontiers in Psychology 2014 Jared R. Lindahl, Christopher T. Kaplan, Evan M. Winget et al. 123 citations

The scientific study of Buddhist meditation has proceeded without much attention to Buddhist literature that details the range of psychological and physiological changes thought to occur during meditation. This paper presents reports of various meditation-induced light experiences derived from American Buddhist practitioners. The reports of light experiences are classified into two main types:...

What can neuroscience tell us about the potential of psychedelics in healthcare? How the neurophenomenology of psychedelics research could help us to flourish throughout our lives, as well as to enhance our dying.

Current Drug Abuse Reviews 2014 Robin Mackenzie 6 citations

Health-related psychedelic research should focus on helping us flourish, not just remedying ill-health or addiction. We don't know enough about how psychedelics could enhance human flourishing. Factors promoting health-through-flourishing include finding meaning in life, spiritual practices, comfortable levels of social bonds, emotionally/physically satisfying sex in a long-term monogamous...

Effects of Stress and MDMA on Hippocampal Gene Expression

BioMed Research International 2014 Georg F. Weber, Bethann N. Johnson, Bryan K. Yamamoto et al. 19 citations

MDMA (3,4-methylenedioxymethamphetamine) is a substituted amphetamine and popular drug of abuse. Its mood-enhancing short-term effects may prompt its consumption under stress. Clinical studies indicate that MDMA treatment may mitigate the symptoms of stress disorders such as posttraumatic stress syndrome (PTSD). On the other hand, repeated administration of MDMA results in persistent deficits...

Traditional Indigenous Medicine of the Peruvian Amazon and its Potential for Psychological Treatment and Personal Growth

Folia Universitatis Agriculturae et Silviculturae Mendelianae Brunensis 2014 Veronika Kavenská 4 citations

This contribution explains the context and basic principles of traditional medicine of the Amazon.In particular, it focuses on the hallucinogenic vine ayahuasca, traditionally used by indigenous communities in the Amazon as a tool for healing, establishing contact with spiritual life, and for many other purposes.In the last decades, there is rapidly growing interest in ayahuasca observed among...

Self-Experimentations with Psychedelics Among Mental Health Professionals: LSD in the Former Czechoslovakia

Journal of Psychoactive Drugs 2014 Petr Winkler, Ladislav Csémy 36 citations

This article enquires into auto-experiments with psychedelics. It is focused on the experiences and current attitudes of mental health professionals who experimented with LSD in the era of legal research of this substance in the former Czechoslovakia. The objective of the follow-up study presented was to assess respondents' long-term views on their LSD experience(s). A secondary objective was...

DOI: 10.1080/02791072.2013.873158 (opens in new tab) Mental health Clinical psychology

Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?

BioMed Research International 2014 Benjamin Rolland, Renaud Jardri, Ali Amad et al. 96 citations

Hallucinations are complex misperceptions, that principally occur in schizophrenia or after intoxication induced by three main classes of drugs: psychostimulants, psychedelics, and dissociative anesthetics. There are at least three different pharmacological ways to induce hallucinations: (1) activation of dopamine D2 receptors (D2Rs) with psychostimulants, (2) activation of serotonin 5HT2A...

DOI: 10.1155/2014/307106 (opens in new tab) Full text (opens in new tab) Hallucinogen Psychosis Schizophrenia object-oriented programming Dissociative +4

The Heffter Research Institute: Past and Hopeful Future

Journal of Psychoactive Drugs 2014 David E. Nichols 24 citations

This essay describes the founding of the Heffter Research Institute in 1993 and its development up to the present. The Institute is the only scientific research organization dedicated to scientific research into the medical value of psychedelics, and it has particularly focused on the use of psilocybin. The first clinical treatment study was of the value of psilocybin in obsessive-compulsive...

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

Frontiers in Human Neuroscience 2014 Robin Carhart-Harris, Robert Leech, Peter J. Hellyer et al. 1,289 citations

Entropy is a dimensionless quantity that is used for measuring uncertainty about the state of a system but it can also imply physical qualities, where high entropy is synonymous with high disorder. Entropy is applied here in the context of states of consciousness and their associated neurodynamics, with a particular focus on the psychedelic state. The psychedelic state is considered an exemplar...

New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?

Drug Testing and Analysis 2014 Claudio Vidal Giné, Iván Fornís Espinosa, Mireia Ventura Vilamala 135 citations

The use of new psychoactive substances (NPS) as adulterants has received little attention in the literature. In this paper, results from Energy Control's drug checking service documenting the use of NPS as adulterants of controlled drugs are presented, and some reflections about possible explanations for this new phenomenon, potential risks for users, and challenges that it poses are discussed....

DOI: 10.1002/dta.1610 (opens in new tab) Full text (opens in new tab) Controlled drugs Illegal market New psychoactive substances Compounds +4